Edwards Lifesciences (EW) Equity Income (2011 - 2013)

Edwards Lifesciences' Equity Income history runs 3 years deep, the most recent figure standing at $200000.0 for Q2 2013.

• In Q2 2013, Equity Income changed N/A year-over-year to $200000.0; the TTM figure through Jun 2013 stood at $4.3 million (changed N/A YoY), while the FY2012 annual figure was $1.8 million, up 157.14% from the prior year.
• Equity Income was $200000.0 for Q2 2013 at Edwards Lifesciences, down from $2.0 million in the prior quarter.
• In the past five years, Equity Income ranged from a high of $2.0 million in Q1 2013 to a low of -$900000.0 in Q1 2011.
• Historically, Equity Income has averaged $625000.0 across 3 years, with a median of $500000.0 in 2011.
• The sharpest annual moves came in 2012 and 2013: Equity Income gained 16.67% in 2012, then surged 185.71% in 2013.
• A 3-year view of Equity Income shows it stood at $1.2 million in 2011, then gained by 16.67% to $1.4 million in 2012, then slumped by 85.71% to $200000.0 in 2013.
• The last three Equity Income figures came in at $200000.0 (Q2 2013), $2.0 million (Q1 2013), and $1.4 million (Q4 2012), per Business Quant data.